Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Conditions

Herpes Zoster 1

Interventions

Imiquimod 2Docetaxel 2Celecoxib 22-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2pembrolizumab 1pasireotide 1gadolinium ethoxybenzyl DTPA 1enzalutamide 1Uterine Myomectomy 1Topotecan 1Tablets 1Sildenafil Citrate 1Reference Standards 1Pentoxifylline 1Mindfulness 1Mass Screening 1Ketoconazole 1Itraconazole 1Hysterectomy 1Hypnosis 1Herpes Zoster Vaccine 1Fecal Microbiota Transplantation 1Exercise 1Estramustine 1Epirubicin 1Doxycycline 1Cryotherapy 1Biopsy, Large-Core Needle 1Azacitidine 1Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × FED × Herpes Zoster Vaccine × Clear all
NCT02444936 2018-04-06

ZOSTAVAX in Persons Imminently Receiving Chemotherapy for Solid Organ Tumors

Louis Stokes VA Medical Center

Phase 4 Unknown
22 enrolled 8 charts

Herpes Zoster

Data powered by HemOnc (CC BY 4.0) Colophon âš¡